Trademark Overview
On Friday, November 15, 2024, a trademark application was filed for DEEPCAUSALAI with the United States Patent and Trademark Office. The USPTO has given the DEEPCAUSALAI trademark a serial number of 98855929. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Friday, November 15, 2024. This trademark is owned by Prescriptive Genomics, Inc. The DEEPCAUSALAI trademark is filed in the Advertising, Business and Retail Services, Computer & Software Products & Electrical & Scientific Products, Insurance & Financial Services, and Computer & Software Services & Scientific Services categories with the following description:
Downloadable computer software for producing financial models; Downloadable computer software using artificial intelligence (AI) for drug discovery and development; Downloadable computer software using artificial intelligence (AI) for therapeutic drug selection and optimization; Downloadable computer software using artificial intelligence (AI) for predicting drug effectiveness, interactions and side effects; Downloadable computer software using artificial intelligence (AI) for therapeutic target selection and optimization; Downloadable computer software using artificial intelligence (AI) for drug design; Downloadable computer software using artificial intelligence (AI) for collecting, analyzing and organizing data in the field of deep learning; Downloadable computer software using artificial intelligence (AI) for generating personal patient treatment plans based on predictive analytics; Downloadable computer software using artificial intelligence (AI) for patient management, treatment,...
Financial analysis, namely, compiling and analyzing statistics, data and other sources of information for financial purposes; Financial data analysis; Financial risk assessment services; Financial advisory and consultancy services, namely, compiling and analyzing statistics, data and other sources of information for financial purposes; Financial advisory and consultancy services, namely, in the area of healthcare
Analyzing and compiling business data for making predictions based on data inputs; Business data analysis; Business research and data analysis services in the field of patient treatment managment; Compiling and analyzing statistics, data and other sources of information for business purposes
Computer software design; Developing computer software; Software as a service (SAAS) services featuring software using artificial intelligence (AI) for drug discovery and development; Software as a service (SAAS) services featuring software using artificial intelligence (AI) for therapeutic drug selection and optimization; Software as a service (SAAS) services featuring software using artificial intelligence (AI) for predicting drug effectiveness, interactions and side effects; Software as a service (SAAS) services featuring software using artificial intelligence (AI) for drug design; Software as a service (SAAS) services featuring software using artificial intelligence (AI) for generating personal patient treatment plans based on predictive analytics; Software authoring; Software design and development